Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
December 21, 2023 09:00 ET
|
Cytek Biosciences, Inc.
The new Cytek Orion reagent cocktail preparation system simplifies & accelerates laboratory workflow, assures consistent experimental results & saves time.
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
November 08, 2023 09:00 ET
|
Cytek Biosciences, Inc.
The Cytek® Aurora™ CS system has been selected as the “Cell Sorting Product of the Year” in the third annual BioTech Breakthrough Awards program.
Cytek Biosciences Reports Third Quarter 2023 Financial Results
November 07, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
September 27, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has received EN ISO 13485:2016 Quality...
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023 16:15 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
September 20, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of...
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
September 14, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis...